Concepedia

Publication | Open Access

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)

82

Citations

21

References

2020

Year

Abstract

Early rituximab intensification during R-CHOP-14 does not improve outcome in patients with untreated DLBCL.

References

YearCitations

Page 1